Nevro Corp (NYSE:NVRO)
$ 5.85 0 (0%) Market Cap: 218.11 Mil Enterprise Value: 186.70 Mil PE Ratio: 0 PB Ratio: 0.79 GF Score: 44/100

Nevro Corp at UBS Global Healthcare Virtual Conference Transcript

May 24, 2021 / 08:00PM GMT
Release Date Price: $149.49 (+0.75%)
Matthew Charles Taylor
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices

Good afternoon, everyone, and thanks for joining us for the next session here in the med tech track of the UBS Global Healthcare Conference. I'm Matt Taylor, the U.S. medical supplies and devices analyst. And I'm really pleased to me joined by the management from Nevro for this session. And so like a lot of our other sessions today, we're going to have a 45-minute fireside chat that I'll moderate, but if you like to ask a question that you want us to merge into the conversation, just e-mail me or anybody on the med tech team or you can also ask questions though the bottom of your screen there in the question function. So as I said, we have Nevro management. So we have both Keith Grossman, he's the Chairman and CEO; Rod MacLeod, the CFO; and Julie Dewey, VP of Investor Relations and Corporate Communications. So the whole team is here today to answer lots of questions across the business. And first, I just want to say thanks to the team, everybody, for making the time we really

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot